GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+5.65%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$190M
Cap. Flow
% of AUM
18.84%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
340
Closed
654
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.02M |
| 2 |
Hilton Worldwide
HLT
|
+$3.96M |
| 3 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$3.79M |
| 4 |
NXP Semiconductors
NXPI
|
+$3.7M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$3.48M |
Top Sells
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.56M |
Sector Composition
| 1 | Technology | 15.84% |
| 2 | Consumer Discretionary | 14.9% |
| 3 | Healthcare | 14.09% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Bridgewater Bancshares
BWB
$453M
| $129K | 0.01% |
+11,941
| New | +$129K |
|
|
VWE
1327
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $129K | 0.01% |
+120,692
| New | +$129K |
|
1328
Nektar Therapeutics
NKTR
$873M
| $127K | 0.01% |
12,024
-30,978
| -72% | -$327K |
|
1329
Vera Therapeutics
VERA
$1.55B
| $126K | 0.01% |
+16,272
| New | +$126K |
|
1330
Passage Bio
PASG
$22.4M
| $125K | 0.01% |
6,509
+1,167
| +22% | +$22.4K |
|
1331
Acacia Research
ACTG
$312M
| $120K | 0.01% |
31,131
-85,333
| -73% | -$329K |
|
1332
ARKO Corp
ARKO
$578M
| $120K | 0.01% |
+14,151
| New | +$120K |
|
1333
Expensify
EXFY
$181M
| $119K | 0.01% |
+14,618
| New | +$119K |
|
|
NESR
1334
National Energy Services Reunited Corp. Ordinary Shares
NESR
$1.01B
| $118K | 0.01% |
+22,513
| New | +$118K |
|
1335
Harvard Bioscience
HBIO
$19.7M
| $117K | 0.01% |
27,854
-87,476
| -76% | -$367K |
|
1336
Heritage Insurance Holdings
HRTG
$721M
| $117K | 0.01% |
37,875
-177,496
| -82% | -$548K |
|
1337
Arbutus Biopharma
ABUS
$972M
| $116K | 0.01% |
38,160
-79,031
| -67% | -$240K |
|
1338
Hudson Technologies
HDSN
$453M
| $116K | 0.01% |
13,250
-33,407
| -72% | -$292K |
|
1339
Janus International
JBI
$1.43B
| $116K | 0.01% |
11,799
-23,255
| -66% | -$229K |
|
1340
Full Truck Alliance
YMM
$14.4B
| $116K | 0.01% |
15,214
-49,749
| -77% | -$379K |
|
|
GOEV
1341
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $116K | 0.01% |
386
+315
| +444% | +$94.7K |
|
1342
CCC Intelligent Solutions
CCCS
$6.3B
| $114K | 0.01% |
+12,764
| New | +$114K |
|
|
IMGN
1343
DELISTED
Immunogen Inc
IMGN
| $114K | 0.01% |
+29,800
| New | +$114K |
|
1344
Amneal Pharmaceuticals
AMRX
$3.24B
| $112K | 0.01% |
80,519
-94,530
| -54% | -$131K |
|
1345
Vera Bradley
VRA
$56.4M
| $112K | 0.01% |
+18,697
| New | +$112K |
|
|
VNET
1346
VNET Group
VNET
$2.5B
| $111K | 0.01% |
+34,300
| New | +$111K |
|
|
TVRD
1347
Tvardi Therapeutics, Inc. Common Stock
TVRD
$325M
| $111K | 0.01% |
+626
| New | +$111K |
|
1348
Grove Collaborative
GROV
$63.6M
| $109K | 0.01% |
+49,824
| New | +$109K |
|
1349
Outlook Therapeutics
OTLK
$49.3M
| $107K | 0.01% |
4,892
-8,997
| -65% | -$197K |
|
1350
FerroAtlántica
GSM
$793M
| $104K | 0.01% |
21,100
-11,257
| -35% | -$55.5K |
|